Biomarkers in Medicine

Biomarkers in Medicine

Biomarkers in Medicine is a comprehensive guide to understanding the current and future status of biomarkers. The book features 27 chapters focusing on disease biomarkers for diseases such as cancer, neurodegenerative diseases, cardiac diseases, metabolic conditions and much more. This book supplies...

Full description

Saved in:
Bibliographic Details
Main Author: Atukeren, Pınar
Other Authors: Uzun, Hafize
Format: eBook
Language:English
Published: Sharjah : Bentham Science Publishers, 2022.
Subjects:
Biomedical engineering.
Radiology.
biomedical engineering.
radiology.
Online Access:Click for online access
Table of Contents:
  • Cover
  • Title
  • Copyright
  • End User License Agreement
  • Contents
  • Preface
  • List of Contributors
  • New Biomarkers and Immunotherapy Decision
  • Abdurrahman Yigit1, Berkay Kuscu2, Ali Kirik2, Ruhsen Ozcaglayan2 and Cigdem Usul Afsar3,*
  • NEW BIOMARKERS AND IMMUNOTHERAPY DECISION
  • Principles of Cancer İmmunotherapy
  • Tumor Immunology
  • Therapeutic Approaches
  • Immune Checkpoint Inhibitors (ICI)
  • THE PREDICTIVE AND PROGNOSTIC MARKERS OF IMMUNOTHERAPY
  • Immunotherapy Toxicity
  • CONCLUSION
  • CONSENT FOR PUBLICATION
  • CONFLICT OF INTEREST
  • ACKNOWLEDGEMENT
  • REFERENCES
  • Biomarkers in Gynecologic Tumors
  • Selim Afsar1,*
  • INTRODUCTION
  • Ovarian and Fallopian Tube Cancers
  • Carbohydrate Antigen 125 (CA125)
  • Screening
  • Prediction Models
  • Prognosis
  • Recurrence
  • Human Epididymis Protein 4 (HE4)
  • Diagnosis
  • Prognosis
  • Risk of Ovarian Malignancy Algorithm (ROMA)
  • Circulating Cell-Free DNA (cfDNA)
  • DNA Methylation
  • Metabolites
  • MicroRNAs
  • Carcinoembryonic Antigen (CEA)
  • Alpha-Fetoprotein (AFP)
  • Inhibin B
  • Human Chorionic Gonadotropin (hCG)
  • Kallikreins
  • Other Markers
  • Uterine Cancer
  • CA125
  • HE4
  • Genomic Classification
  • Other Markers
  • Cervical Cancer
  • Squamous Cell Carcinoma Antigen (SCC-Ag)
  • Other Markers
  • CONCLUSION
  • CONSENT FOR PUBLICATION
  • CONFLICT OF INTEREST
  • ACKNOWLEDGEMENT
  • REFERENCES
  • Biomarkers in Urological Cancers
  • Bulent Onal1,*, Mehmet Hamza Gultekin1, Muhammed Fatih Simsekoglu1, Berin Selcuk1 and Ahmet Gurbuz1
  • BIOMARKERS IN BLADDER CANCER
  • Blood-based Biomarkers
  • Tumor Cells
  • CD8 Count and Immune Cells
  • Matrix Metalloproteinase
  • Epigenetic Markers
  • Tissue-based Biomarkers
  • Cell Cycle-based Markers
  • Transmembrane- and Signaling-based Markers
  • PDL/PDL1
  • MTOR
  • MDR1
  • Human Epidermal Growth Factor Receptor 2 (HER2)
  • Apoptosis- and DNA Repair-Based Markers
  • Multiplexed Markers
  • Twenty-Gene Panel, GenomeDX Gene-Expression Assay
  • Urine-based Biomarkers
  • Fluorescence In situ Hybridization (FISH)
  • Bladder Tumor Antigen (BTA) Tests
  • Nuclear Matrix Protein-22 (NMP-22) Test
  • ImmunoCyt Test
  • CxBladder Test
  • SUMMARY
  • BIOMARKERS IN PROSTATE CANCER
  • Blood-Based Biomarkers
  • PSA or hK3
  • Free PSA (fPSA)
  • Prostate Health Index (PHI)
  • 4Kscore Test
  • Circulating Tumor Cells (CTCs) and Circulating Tumor DNA (ctDNA)

Similar Items